MARKET

SSKN

SSKN

STRATA Skin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.720
-0.030
-1.71%
After Hours: 1.750 +0.03 +1.74% 19:13 04/16 EDT
OPEN
1.720
PREV CLOSE
1.750
HIGH
1.740
LOW
1.670
VOLUME
788.65K
TURNOVER
--
52 WEEK HIGH
2.840
52 WEEK LOW
0.8500
MARKET CAP
58.14M
P/E (TTM)
-13.0998
1D
5D
1M
3M
1Y
5Y
UPDATE 2-Modi appeals for low-key Hindu festival as India's COVID-19 infections surge
reuters.com · 1d ago
8-K: STRATA Skin Sciences, Inc.
-------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 5d ago
BRIEF-Strata Skin Sciences Appoints William Humphries To Board Of Directors
reuters.com · 6d ago
Press Release: STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
Dow Jones · 6d ago
Vitiligo Drugs Market Growth Analysis, Share, Demand by Regions, Types and Analysis of Key Players- Research Forecasts to 2027
Apr 12, 2021 (Market Insight Reports) -- Vitiligo is a medical condition characterized by white patches on the skin and is also known as skin depigmentation....
Market Insight Reports · 6d ago
Non-Surgical Skin Tightening Market Research Report: Recent Trends, Top Players, Comprehensive Evaluation of Business Share Forecast to 2025
Apr 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Non-Surgical Skin Tightening...
The Express Wire · 6d ago
Pigmented Lesion Treatment Market Intelligence Is Poised To Value Over USD 541.9 Mn By 2028 | CAGR 7.2%
Apr 12, 2021 (WiredRelease via Comtex) -- Market.us adopted a multidisciplinary detain during the pandemic-era to focus on the revolutionary trends, growth...
marketresearch.biz · 6d ago
Dermatologist Suggest the Best "Hair Removal Devices", that Offering Multi-Services to Propel Growth
Market Insight Reports · 04/10 10:18
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SSKN. Analyze the recent business situations of STRATA Skin through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SSKN stock price target is 4.000 with a high estimate of 5.00 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 36
Institutional Holdings: 12.52M
% Owned: 37.04%
Shares Outstanding: 33.80M
TypeInstitutionsShares
Increased
5
128.36K
New
4
1.66M
Decreased
5
10.18K
Sold Out
4
10.44K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.19%
Healthcare Equipment & Supplies
+0.17%
Key Executives
Chairman/Director
Uri Geiger
President/Chief Executive Officer/Director
Robert Moccia
Vice Chairman/Director
LuAnn Via
Chief Financial Officer
Matthew Hill
Independent Director
William Humphries
Independent Director
Samuel Navarro
Independent Director
Samuel Rubinstein
Independent Director
Nachum Shamir
Independent Director
David Stone
No Data
  • All
  • Financials
  • Insiders
More
About SSKN
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

Webull offers kinds of STRATA Skin Sciences Inc stock information, including NASDAQ:SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SSKN stock methods without spending real money on the virtual paper trading platform.